CN101390988A - Medicine for treating hyperosteogeny - Google Patents

Medicine for treating hyperosteogeny Download PDF

Info

Publication number
CN101390988A
CN101390988A CNA2008101582019A CN200810158201A CN101390988A CN 101390988 A CN101390988 A CN 101390988A CN A2008101582019 A CNA2008101582019 A CN A2008101582019A CN 200810158201 A CN200810158201 A CN 200810158201A CN 101390988 A CN101390988 A CN 101390988A
Authority
CN
China
Prior art keywords
radix
medicine
hyperosteogeny
root
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2008101582019A
Other languages
Chinese (zh)
Other versions
CN101390988B (en
Inventor
侯召亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hou Zhaoliang
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101582019A priority Critical patent/CN101390988B/en
Publication of CN101390988A publication Critical patent/CN101390988A/en
Application granted granted Critical
Publication of CN101390988B publication Critical patent/CN101390988B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a medicine for curing hyperosteogeny, which is composed of following raw materials: hartshorn 24, tortoise plastron 24, turtle shell 24, beef tendon 30, oxhide gelatin 20, panax notoginseng 24, eucommia bark 20, teasel root 20, Chickens Gizzard-membrane 18, green hawthorn 50, kadsura root 18, Thickleaf Croton Root 18, safflower 15, Root of Lineate Supplejack 15, ground ivy 15, marinated snake tendon 15, cairo morningglory root 18, Philippine Flemingia Root 18, prepared rhizome of rehmannia 30, Tuckahoe 18, loranthus parasiticus 18 and psoralea 50. The medicine has the advantages that the curative effect is rapid, the recovery ratio is high, the usage is convenient without side effects; thus being an ideal medicine for curing the hyperosteogeny. The medicine can reach 100% effective ratio in curing the hyperosteogeny, and the recovery ratio can reach 98%.

Description

A kind of medicine for the treatment of hyperosteogeny
Technical field
The present invention relates to the super cell grade micropowder of pure Chinese herbal medicine (more than 300 orders) technical field, specifically a kind of medicine for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is present a kind of modal joint disease, at the osteoarthrosis place bony spur pressuring nerve takes place and causes numb hand and foot pain, and it is unfavorable to bend and stretch walking, neck and lumbar pain, sciatic nerve pain, headache etc.These are sick many by the Kidney-Yin tool void of Liver and kidney, and muscles and bones mistake is supported and caused distortion, enlargement, long bone thorn; So-called " Kidney-Yin " promptly be " scleroprotein " collagen fiber said on the modern medicine and.Or injure the joint and cause qi depression to blood stasis to cause distortion in the joint by wound, enlargement, long bone thorn.At present, the medicine of treatment hyperosteogeny is existed everywhere on the market, as: GUCIPING PIAN (Guangxi thousand side pharmaceutcal corporation, Ltds), spur and pain relieving liquid (Beijing Tongrentang Medical Wine Factory, Beijing Tongrentang Co Ltd) or the like, really number is also countless, be principle of treatment all to relieve the pain, cure rate is low, can only take stopgap measures to effect a permanent cure, and all can not fundamentally cure the curing hyperosteogeny disease.
The invention reside in provides a kind of medicine for the treatment of hyperosteogeny, thereby the purpose of invention is to reach rapid healing hyperosteogeny.
Summary of the invention
The Therapeutic Method that the present invention adopts is the super cell grade micropowder of pure Chinese herbal medicine (more than 300 an orders) powder Therapeutic Method.
Technical problem to be solved by this invention is: a kind of curative effect height is provided, and controls the medicine of fast treatment hyperosteogeny.
Technical scheme is:
A kind of medicine for the treatment of hyperosteogeny is characterized in that its raw material deal proportioning is:
Cornu Cervi 10-24, Carapax et Plastrum Testudinis 10-24, Carapax Trionycis 10-24, Ungula Bovis seu Bubali muscle 10-30, gelatinum oxhide 10-20, Radix Notoginseng 10-30, the Cortex Eucommiae 10-24, Radix Dipsaci 10-24, Endothelium Corneum Gigeriae Galli 10-30, Fructus Crataegi 10-50, Caulis Kadsurae Coccineae 10-20, Radix Crotonis Crassifolii 10-24, Flos Carthami 10-20, Radix berchemiae lineatae 10-24, Radix seu Folium Gaultheriae Forrestii 10-24, She Pao le 10-24, Herba Ipomoeae Cairicae 10-24, Radix Flemingiae Philippinensis 10-24, Radix Rehmanniae Preparata 10-30, Poria 10-20, Herba Taxilli 10-24, Fructus Psoraleae 20-50.
A kind of medicine for the treatment of hyperosteogeny is characterized in that its raw material deal proportioning is:
Cornu Cervi 24, Carapax et Plastrum Testudinis 24, Carapax Trionycis 24, Ungula Bovis seu Bubali muscle 30, gelatinum oxhide 20, Radix Notoginseng 24, the Cortex Eucommiae 20, Radix Dipsaci 20, Endothelium Corneum Gigeriae Galli 18, Fructus Crataegi 50, Caulis Kadsurae Coccineae 18, Radix Crotonis Crassifolii 18, Flos Carthami 15, Radix berchemiae lineatae 15, Radix seu Folium Gaultheriae Forrestii 15, She Pao le 15, Herba Ipomoeae Cairicae 18, Radix Flemingiae Philippinensis 18, Radix Rehmanniae Preparata 30, Poria 18, Herba Taxilli 18, Fructus Psoraleae 50.
Drug action mechanism of the present invention is as follows:
The Cornu Cervi warming the kidney to invigorate YANG, bone and muscle strengthening, promoting the circulation of blood detumescence; The Carapax et Plastrum Testudinis nourishing YIN for suppressing the hyperactive YANG, replenishing kidney and strengthening bone; The Carapax Trionycis nourishing YIN for suppressing the hyperactive YANG, San Jie Xiao wei; Ungula Bovis seu Bubali muscle is mended scleroprotein, collagen fiber; Gelatinum oxhide is nourshing Yin and drynsessmoistening prescription, nourishing blood and hemoslasis, promoting blood circulation and detumescence, detoxifcation, scleroprotein, collagen fiber; Radix Notoginseng is dispelled to become silted up and stops blooding reducing swelling and alleviating pain; Cortex Eucommiae invigorating the liver and kidney, bone and muscle strengthening, antiabortive; The Radix Dipsaci invigorating the liver and kidney, bone and muscle strengthening ends metrorrhagia, and is antiabortive; The Fructus Psoraleae kidney invigorating and YANG supporting; The Endothelium Corneum Gigeriae Galli promoting digestion and removing stagnation, arresting enursis, fossil is treating stranguria; The Fructus Crataegi dyspepsia and intestinal stasis relieving, blood stasis-eliminating and stagnation-dissipating; The Caulis Kadsurae Coccineae promoting the circulation of QI to relieve pain, activating blood and removing stasis, Eradicates rheumatism; The Radix Crotonis Crassifolii promoting the circulation of QI to relieve pain, the Eradicates wind and removing obstruction in channels; The Flos Carthami promoting blood circulation to restore menstrual flow, the silt pain relieving of dispelling; The Radix berchemiae lineatae silt pain relieving of dispelling, the soothing liver-QI jaundice eliminating, the cough-relieving of reason lung, the infantile malnutrition that disappears is good for the stomach; The Radix seu Folium Gaultheriae Forrestii activating blood and removing stasis, granulation promoting synthetism, relieving stranguria by diuresis, dampness removing jaundice eliminating, expelling phlegm for arresting cough; She Pao le activating blood and removing stasis, synthetism granulation promoting, relieving stranguria by diuresis, the heat clearing away of Eradicates wind; The Herba Ipomoeae Cairicae invigorating the spleen and replenishing QI, eliminating phlegm and relieving asthma, invigorating the spleen for eliminating dampness; The Radix Flemingiae Philippinensis invigorating the spleen and replenishing QI, invigorating the liver and kidney, bone and muscle strengthening, relaxing muscles and tendons and activating QI and blood in the collateral; Radix Rehmanniae Preparata is enriched blood, YIN nourishing; The Poria promoting diuresis to eliminate damp pathogen, spleen invigorating invigorating middle warmer, mind tranquilizing and the heart calming; The Herba Taxilli invigorating the liver and kidney, bone and muscle strengthening, Eradicates rheumatism, nourishing blood and preventing abortion.
Press: the side in Radix Rehmanniae Preparata, Cornu Cervi, Carapax et Plastrum Testudinis, Carapax Trionycis, gelatinum oxhide, the Cortex Eucommiae, Radix Dipsaci, Herba Taxilli, Ungula Bovis seu Bubali muscle nourishing the liver and kidney, bone and muscle strengthening, replenish the calcium, mend scleroprotein, collagen fiber are main; Be aided with Radix Notoginseng, Flos Carthami, Radix seu Folium Gaultheriae Forrestii, She Pao le, Radix berchemiae lineatae activating blood circulation to dissipate blood stasis, reducing swelling and alleviating pain; Assistant is with Endothelium Corneum Gigeriae Galli, Fructus Crataegi, Caulis Kadsurae Coccineae, Radix Crotonis Crassifolii promoting digestion and removing stagnation, promoting the circulation of QI to relieve pain, blood stasis-eliminating and stagnation-dissipating; Calcium, phosphorus, eliminating dampness and diuresis are for making in Fructus Psoraleae, the Poria increase blood; Radix Flemingiae Philippinensis, Herba Ipomoeae Cairicae two medicines share to strengthen the effect of air making-up and spleen enlivening; All medicines are harmonious, and bring out the best in each other, gather altogether nourishing liver and kidney, mend scleroprotein, collagen fiber, eliminate the merit of sclerotin thorn, activating blood circulation to dissipate blood stasis, reducing swelling and alleviating pain, effect with rapid healing hyperosteogeny.After the process of preparing Chinese medicine of will adding medicine to processes, make super cell grade micropowder (more than 300 orders) powder then altogether and bottle standby.
Drug therapy hyperosteogeny curative effect of the present invention is fast, the cure rate height, and taking convenience has no side effect, and is a kind of medicine of ideal treatment hyperosteogeny.Drug therapy hyperosteogeny effective percentage 100% of the present invention, cure rate 98%
Using method:
1, day clothes are three times, and powder 6-9 grams of at every turn getting it filled are put into 300-500 milliliters of boiled water and soaked 15-20 minutes, wait under the decoction being taken warmly taking medicine after meal.
2, the course of treatment: 15-30 days is a course of treatment, and the lighter can cure 1-2 courses of treatment, and heavy person can cure 2-3 courses of treatment.
Through 524 routine hyperosteogeny patient's clinical treatments are added up, wherein the hyperosteogeny of cervical vertebra patient 213, lumbar vertebra vertebra matter hypertrophy patient 158, knee joint hyperosteogeny patient 121, old fracture damage hyperosteogeny patient 32, clinical cure 513 examples, effective 11 examples, total effective rate 100%, cure rate 98%.Show that medicine of the present invention has higher clinical efficacy, it does not find tangible untoward reaction at the treatment viewing duration, shows that safety of medicine of the present invention is effective.
The specific embodiment
Embodiment: get: Cornu Cervi 24, Carapax et Plastrum Testudinis 24, Carapax Trionycis 24, Ungula Bovis seu Bubali muscle 30, gelatinum oxhide 20, Radix Notoginseng 24, the Cortex Eucommiae 20, Radix Dipsaci 20, Endothelium Corneum Gigeriae Galli 18, Fructus Crataegi 50, Caulis Kadsurae Coccineae 18, Radix Crotonis Crassifolii 18, Flos Carthami 15, Radix berchemiae lineatae 15, Radix seu Folium Gaultheriae Forrestii 15, She Pao le 15, Herba Ipomoeae Cairicae 18, Radix Flemingiae Philippinensis 18, Radix Rehmanniae Preparata 30, Poria 18, Herba Taxilli 18, Fructus Psoraleae 50.After the process of preparing Chinese medicine of will adding medicine to processes, make super cell grade micropowder (more than 300 orders) powder dress then altogether and medicated powder is bottled standby.
Drug therapy hyperosteogeny curative effect of the present invention is fast, the cure rate height, and taking convenience has no side effect, and is a kind of medicine of ideal treatment hyperosteogeny.Drug therapy hyperosteogeny effective percentage 100% of the present invention, cure rate 98%.
Using method:
1, day clothes are three times, and powder 6-9 grams of at every turn getting it filled are put into 300-500 milliliters of boiled water and soaked 15-20 minutes, wait under the decoction being taken warmly taking medicine after meal.
2, the course of treatment: 15-30 days is a course of treatment, and the lighter can cure 1-2 courses of treatment, and heavy person can cure 2-3 courses of treatment.
Through 524 routine hyperosteogeny patient's clinical treatments are added up, wherein the hyperosteogeny of cervical vertebra patient 213, lumbar vertebra vertebra matter hypertrophy patient 158, knee joint hyperosteogeny patient 121, old fracture damage hyperosteogeny patient 32, clinical cure 513 examples, effective 11 examples, total effective rate 100%, cure rate 98%.Show that medicine of the present invention has higher clinical efficacy, its treatment viewing duration not wind find tangible untoward reaction, show that safety of medicine of the present invention is effective.

Claims (2)

1, a kind of medicine for the treatment of hyperosteogeny is characterized in that: its raw material deal proportioning is: Cornu Cervi 10-24, Carapax et Plastrum Testudinis 10-24, Carapax Trionycis 10-24, Ungula Bovis seu Bubali muscle 10-30, gelatinum oxhide 10-20, Radix Notoginseng 10-30, the Cortex Eucommiae 10-24, Radix Dipsaci 10-24, Endothelium Corneum Gigeriae Galli 10-30, Fructus Crataegi 10-50, Caulis Kadsurae Coccineae 10-20, Radix Crotonis Crassifolii 10-24, Flos Carthami 10-20, Radix berchemiae lineatae 10-24, Radix seu Folium Gaultheriae Forrestii 10-24, She Pao le 10-24, Herba Ipomoeae Cairicae 10-24, Radix Flemingiae Philippinensis 10-24, Radix Rehmanniae Preparata 10-30, Poria 10-20, Herba Taxilli 10-24, Fructus Psoraleae 20-50.
2, a kind of medicine for the treatment of hyperosteogeny is characterized in that: its raw material deal proportioning is: Cornu Cervi 24, Carapax et Plastrum Testudinis 24, Carapax Trionycis 24, Ungula Bovis seu Bubali muscle 30, gelatinum oxhide 20, Radix Notoginseng 24, the Cortex Eucommiae 20, Radix Dipsaci 20, Endothelium Corneum Gigeriae Galli 18, Fructus Crataegi 50, Caulis Kadsurae Coccineae 18, Radix Crotonis Crassifolii 18, Flos Carthami 15, Radix berchemiae lineatae 15, Radix seu Folium Gaultheriae Forrestii 15, She Pao le 15, Herba Ipomoeae Cairicae 18, Radix Flemingiae Philippinensis 18, Radix Rehmanniae Preparata 30, Poria 18, Herba Taxilli 18, Fructus Psoraleae 50.
CN2008101582019A 2008-10-23 2008-10-23 Medicine for treating hyperosteogeny Expired - Fee Related CN101390988B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101582019A CN101390988B (en) 2008-10-23 2008-10-23 Medicine for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101582019A CN101390988B (en) 2008-10-23 2008-10-23 Medicine for treating hyperosteogeny

Publications (2)

Publication Number Publication Date
CN101390988A true CN101390988A (en) 2009-03-25
CN101390988B CN101390988B (en) 2012-04-25

Family

ID=40491629

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101582019A Expired - Fee Related CN101390988B (en) 2008-10-23 2008-10-23 Medicine for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN101390988B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274475A (en) * 2011-07-15 2011-12-14 莫桂森 Ostalgia moxibustion
CN102599387A (en) * 2012-03-23 2012-07-25 蒋勇 Traditional Chinese medicine additive for fattening cattle and applications thereof
CN103083630A (en) * 2012-11-11 2013-05-08 李传深 Plaster for treating osteoproliferation
CN103656001A (en) * 2013-12-18 2014-03-26 青岛市市立医院 Compound medicine for treating osteoproliferation
CN105327328A (en) * 2015-12-12 2016-02-17 林炜 Formula for treating osteoproliferation
CN106177775A (en) * 2016-08-23 2016-12-07 姚洪超 A kind of Chinese medicine composition treating hyperosteogeny
CN109260425A (en) * 2018-12-10 2019-01-25 李天基 A kind of Chinese medicine composition for treating osteoproliferation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1061550C (en) * 1997-08-15 2001-02-07 刘福印 Medicine for treating osteoporosis and its preparing method
CN100502915C (en) * 2005-01-11 2009-06-24 陈惜春 Chinese medicinal herb capsule for treating hyperosteogeny

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274475A (en) * 2011-07-15 2011-12-14 莫桂森 Ostalgia moxibustion
CN102274475B (en) * 2011-07-15 2013-09-04 莫桂森 Ostalgia moxibustion
CN102599387A (en) * 2012-03-23 2012-07-25 蒋勇 Traditional Chinese medicine additive for fattening cattle and applications thereof
CN103083630A (en) * 2012-11-11 2013-05-08 李传深 Plaster for treating osteoproliferation
CN103656001A (en) * 2013-12-18 2014-03-26 青岛市市立医院 Compound medicine for treating osteoproliferation
CN105327328A (en) * 2015-12-12 2016-02-17 林炜 Formula for treating osteoproliferation
CN106177775A (en) * 2016-08-23 2016-12-07 姚洪超 A kind of Chinese medicine composition treating hyperosteogeny
CN109260425A (en) * 2018-12-10 2019-01-25 李天基 A kind of Chinese medicine composition for treating osteoproliferation

Also Published As

Publication number Publication date
CN101390988B (en) 2012-04-25

Similar Documents

Publication Publication Date Title
CN101390988B (en) Medicine for treating hyperosteogeny
CN103316141B (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN102698092A (en) Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension
CN102058801A (en) Rhinitis ointment for dredging orifices
CN101549137A (en) Chinese medicine preparation for treating bone joint disease
CN103356953B (en) A kind of Chinese medicine composition for the treatment of lumbar muscle strain
CN103446386B (en) A kind of Chinese medicine composition for the treatment of lumbago
CN102406810A (en) Bonesetting medicinal liquor capable of being taken orally and externally applying
CN106110216A (en) Treat neurasthenic Chinese medicinal formulae
CN101601767A (en) A kind of Chinese medicine lotion for the treatment of calcaneodynia
CN103230535A (en) Medicinal liquor with function of activating collaterals to ease pain
CN1076619C (en) Moxiburning medicine for acupoint therapy
CN106344854A (en) Blood-invigorating and tendon-relaxing foot bath powder and preparation method thereof
CN104784417A (en) Traditional Chinese medicine composition for curing impotentia
CN104324186A (en) Traditional Chinese medicine prescription for treating climacteric syndrome, and preparation methods of capsule and ointment of traditional Chinese medicine prescription
CN101152329A (en) Medicament for treating flab pain
CN102406789B (en) Plaster for treating cervical spondylosis
CN106177162A (en) A kind of alleviate battle-weary champignon of motion and preparation method thereof
CN105641187A (en) Far-infrared therapeutic plaster
CN101229356B (en) External wad for treating cervical spondylosis
CN106109630A (en) For treating the Chinese medicine composition of cervical spondylosis
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN104922454A (en) Orally-taken medicine for treating soft tissue contusion and preparation method thereof
CN104922592A (en) Traditional Chinese medicine composition for treating lumbago
CN103705712A (en) Traditional Chinese medicine preparation for treating osteoporosis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C53 Correction of patent for invention or patent application
C56 Change in the name or address of the patentee
CB03 Change of inventor or designer information

Inventor after: Hou Zhaoliang

Inventor before: Hou Zhaoliang

CP01 Change in the name or title of a patent holder

Address after: 252313 Shandong city of Liaocheng province Yanggu County Jin Dou Ying Xiang Lian Hua Chi Village No. 122

Patentee after: Hou Zhaoliang

Address before: 252313 Shandong city of Liaocheng province Yanggu County Jin Dou Ying Xiang Lian Hua Chi Village No. 122

Patentee before: Hou Zhaoliang

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120425

Termination date: 20131023